期刊
CURRENT OPINION IN HEMATOLOGY
卷 23, 期 3, 页码 280-287出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MOH.0000000000000237
关键词
extracellular matrix; fibrinogen; fibronectin; platelet; von Willebrand factor
类别
资金
- Canadian Institutes of Health Research [MOP 119540]
- Heart and Stroke Foundation of Canada (Ontario)
- Canadian Blood Services
- Meredith AMP
- Malcolm Silver Scholarship in Cardiovascular Studies from the University of Toronto
- University of Toronto
Purpose of reviewExposure of subendothelial extracellular matrix (ECM) proteins to the circulation is the key event that initiates platelet accumulation and clot formation after vessel injury. Soluble ECM proteins are also essential for support and regulation of these events. This review discusses the current understanding of ECM proteins in thrombosis and hemostasis.Recent findingsFibrinogen and von Willebrand factor (VWF) are considered essential for thrombosis and hemostasis. Interestingly, IIb3 integrin-dependent thrombus formation persists in the absence of fibrinogen and VWF, suggesting that other IIb3 ligand (s), likely ECM proteins, can still mediate thrombosis. Fibronectin increases in platelets of fibrinogen-deficient humans and mice. This ECM protein can rapidly deposit onto the injured vessel wall prior to platelet accumulation. By switching from the soluble to insoluble form, plasma fibronectin supports hemostasis and inhibits excessive thrombosis. Fibrin, fibronectin, VWF, vitronectin, neutrophil extracellular traps, and other ECM proteins in the blood clot form a de-facto ECM, which interacts with various types of blood cells to regulate the evolution and resolution of the clot.SummaryECM proteins are intricately involved in major steps of thrombus formation. Further investigations of ECM proteins will reveal new therapeutic targets for treatment of thrombosis and bleeding disorders.Video abstracthttp://links.lww.com/COH/A12
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据